Thyroid cancer (THCA) remains a prevalent endocrine malignancy, with limited molecular markers for accurate diagnosis and targeted therapy. This study aimed to identify key biomarkers and therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results